Depression vulnerability and 5-hydroxytryptophan prophylaxis
Authors:
- Herman van PraagHPHerman van Praag
- Sietse de HaanSHSietse de Haan
- 1 September 1980
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 3 (1) , 75-83
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- L-5-Hydroxytryptophan in Depression: the First Substitution Therapy in Psychiatry?Neuropsychobiology, 1980
- L-5-HTP Treatment and Serum 5-HT Level after L-5-HTP Loading on Depressed PatientsNeuropsychobiology, 1979
- Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1977
- New Evidence of Serotonin-Deficient DepressionsNeuropsychobiology, 1977
- Intravenous L-5-Hydroxytryptophan in Normal Subjects: An Interdisciplinary Precursor Loading StudyPharmacopsychiatry, 1976
- L-5-HYDROXYTRYPTOPHAN AND MOODThe Lancet, 1975
- DECARBOXYLATION OF EXOGENOUS l‐5‐HYDROXYTRYPTOPHAN AFTER DESTRUCTION OF THE CEREBRAL RAPHE SYSTEMJournal of Neurochemistry, 1974
- Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decar☐ylase inhibitionBrain Research, 1972
- 5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with ProbenecidNature, 1970
- INTENSIFICATION OF THE CENTRAL SEROTONINERGIC PROCESSES AS A POSSIBLE DETERMINANT OF THE THYMOLEPTIC EFFECTThe Lancet, 1969